< content="width=device-width, initial-scale=1.0"> John P. Barbuto | School of Medicine
John P. Barbuto

John P. Barbuto, MD

Languages spoken: English

Academic Office Information

John.Barbuto@utah.edu

Selected Publications

Journal Article

  1. Barbuto JP (2008). Depression & just what I thought. J Manag Care Pharm, 14(6), 561-2.
  2. Jackson M, Barbuto JP (2008). Botox, migraine, and the American Academy of Neurology: an antidote to anecdote. J Manag Care Pharm, 14(5), 465-7.
  3. Barbuto JP, Summers KH, Payakachat N (2006). Comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults. J Manag Care Pharm, 12(3), 270-1.
  4. Fitzgibbon ML, Barbuto J (1989). Approach to the medically ill borderline patient: a case study. Psychol Rep, 65(3 Pt 2), 1091-6.
  5. Barbuto J (1983). Preventing sudden death during a catatonic episode. Hosp Community Psychiatry, 34(1), 72-3.

Review

  1. Barbuto JP, White GL Jr, Porucznik CA, Holmes EB (2008). Chronic pain: second, do no harm. [Review]. Am J Phys Med Rehabil, 87(1), 78-83.
  2. Payakachat N, Summers KH, Barbuto JP (2006). A comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults. [Review]. J Manag Care Pharm, 12(1), 55-60.

Editorial

  1. Barbuto JP (2005). ADHD: disease or social misfit? J Manag Care Pharm, 11(4), 342-3.
  2. Barbuto JP (2005). Bipolar disorder pills in perspective: questions from peer review. J Manag Care Pharm, 11(1), 88-9.
  3. Barbuto JP (2003). Use of drugs for off-label indications: living in the same world. J Manag Care Pharm, 9(6), 570-1.
  4. Barbuto JP (2003). Beyond narcotics for effective pain management. J Manag Care Pharm, 9(2), 175-6.
  5. Barbuto JP (2003). Out of illness, into life: pain management and the need for triptans. J Manag Care Pharm, 9(1), 89-90.
  6. Barbuto JP (2002). Gabapentin and indications of appropriate use. J Manag Care Pharm, 8(4), 293-4.

Letter

  1. Barbuto JP (2004). Categorizing patients from medical claims data--the influence of GIGO. [Letter to the editor]. J Manag Care Pharm, 10(6), 559-60.
  2. Barbuto JP (2003). Patient-reported utilization patterns of narcotic drugs. [Letter to the editor]. J Manag Care Pharm, 9(4), 374-5.
  3. Barbuto JP (1994). Breast implants and autoimmunity. [Letter to the editor]. West J Med, 161(1), 90-1; discussion 91-2.
  4. Barbuto JP (1994). Requiem for medicine? [Letter to the editor]. West J Med, 160(6), 582-3.
  5. Barbuto JP (1989). 'Minor' can be a source of major debate. [Letter to the editor]. West J Med, 151(3), 330.